CPAP can control obstructive sleep apnea well, but the treatment only works when a patient can sleep with it. Masks can leak. Hoses move. Some patients keep trying different settings and equipment and still cannot use PAP enough to control their sleep apnea.
Genio® gives select adults another option. This surgical sleep apnea treatment uses hypoglossal nerve stimulation to help keep the tongue from blocking the airway during sleep. Unlike systems with a battery implanted in the chest, Genio uses one battery-free stimulator placed under the chin and an external sleep wearable that powers treatment at night. ENT Specialists offers evaluation for Genio sleep apnea treatment in Novi for patients from Novi, Brighton, and Bingham Farms.
The New Option
Genio is an FDA-approved hypoglossal nerve stimulation treatment for select adults with moderate to severe obstructive sleep apnea. A small battery-free stimulator is implanted under the chin, where it stimulates nerves on both sides of the tongue to help maintain an open airway during sleep.
The hypoglossal nerves control muscles that move the tongue. Genio delivers stimulation to nerve branches on both sides, causing the tongue muscles to contract and move forward enough to reduce airway blockage.
The implant has no internal battery. At bedtime, the patient attaches an activation chip to a disposable adhesive patch and places it under the chin. The activation chip powers the implanted stimulator through the skin.
The FDA approved Genio System 2.1 in August 2025 for adults age 22 and older with an apnea-hypopnea index, or AHI, from 15 through 65 who meet the approved treatment criteria.
Airway Meets Muscle
Obstructive sleep apnea occurs when tissues in the upper airway narrow or collapse during sleep. The tongue can contribute to that blockage, especially after the muscles relax.
Genio works at the muscle level. The implant sits under the chin over the genioglossus muscle, a major muscle responsible for moving the tongue forward. Its electrodes face branches of the hypoglossal nerve on both sides. When stimulation reaches those nerves, the tongue muscles contract and help create more room for air to pass.
One implant does the work. There is no sensing lead placed in the chest and no battery implanted under the skin.
Before bed, the patient connects the rechargeable activation chip to a fresh adhesive patch and places it over the implant site. Stimulation begins after the programmed start delay. In the morning, the patient removes the wearable, discards the patch, and puts the activation chip back on its charger.
The optional Genio smartphone app can start or pause treatment, adjust stimulation within limits set by the care team, and track device use.
The appeal of Genio comes from a different hardware setup and a different bedtime routine than PAP therapy or some other implanted sleep apnea systems.
Potential benefits include:
The absence of an internal battery also means there is no implanted battery that has to be replaced after it reaches the end of its service life.
Genio is MR Conditional for 1.5T and 3T MRI scans when the required conditions are followed.
Genio is intended for a defined group of adults with moderate to severe obstructive sleep apnea. A consultation starts with the sleep study, prior treatment history, airway exam, and medical history.
Under its current FDA indication, Genio may be considered for patients who:
PAP failure can include persistent OSA despite PAP use. PAP intolerance can include an inability to meet required use or a decision to stop PAP after starting treatment.
Who May Not Be a Good Candidate?
An implant should solve the airway problem a patient has. It should not be selected because the device sounds easier than CPAP.
Genio may not fit patients with a high percentage of central or mixed sleep apnea events, medical conditions that make surgery unsafe, certain implanted electronic devices, or structural problems that interfere with treatment.
The FDA labeling also notes patient groups in which safety and effectiveness have not been established, including adults older than 75, patients with a BMI above 32 kg/m², and patients with complete concentric collapse at the soft palate level.
ENT Specialists evaluates the full airway before recommending surgery. Nose, palate, tongue position, throat structure, sleep-study findings, and prior treatment all influence the plan.
Preparation begins before an operating room date is chosen.
The purpose of the workup is simple: confirm that Genio matches the cause of the obstruction.
Finding The Right Setting
Genio implantation is an outpatient surgical procedure performed through a single incision under the chin.
The surgeon positions the small stimulator over the genioglossus muscle. Electrodes on the implant face branches of the hypoglossal nerves on the left and right sides. The implant is secured to the muscle, then the incision is closed.
There is no chest incision for a battery and no sensing lead placed between the ribs. The stimulator under the chin is the only implanted component of Genio. FDA documentation confirms that the device is implanted through one incision and stimulates both left and right hypoglossal nerve branches.
Once the surgical site heals enough, the therapy moves into activation and programming. The physician sets a treatment range that balances tongue movement with comfort.
Patients can feel tongue movement or a mild pulling sensation when stimulation starts. The goal is enough muscle contraction to help open the airway without creating stimulation that keeps the patient awake.
Settings are adjusted over time as the patient becomes accustomed to treatment and the care team reviews sleep response. If the patient wakes during the night, Genio can be paused and restarted before falling asleep again.
At bedtime, there is still a routine. The activation chip connects to the adhesive patch, the patch goes under the chin, and the chip powers the implanted stimulator during sleep.
Recovery centers on the small surgical area under the chin. Swelling, tenderness, bruising, tightness, and throat or tongue discomfort can occur during early healing.
Patients may also notice temporary swallowing discomfort or altered sensation around the treatment area. The incision needs time before normal activity returns.
The first few days focus on incision care, swelling, and comfort. Patients should follow the surgeon’s instructions for bathing, eating, medications, and activity.
Desk work and normal errands may return before exercise or strenuous activity. Timing depends on healing, the patient’s work, and the physician’s restrictions.
The implant is not the end of treatment. After healing, therapy must be activated and programmed. Follow-up visits give the care team a chance to adjust the stimulation range and review how well treatment controls obstructive events.
Patients should contact the office for increasing redness, drainage, fever, severe swelling, worsening pain, new tongue weakness, trouble swallowing, or breathing concerns.
The Sleep Study Tells
The goal of Genio is to reduce obstructive breathing events during sleep while giving patients an alternative to mask-based therapy.
The pivotal DREAM study gives useful context. At 12 months, 66.4% of participants in the full analysis set met the AHI responder definition, which required at least a 50% reduction in AHI and an AHI below 20. 74.5% met the oxygen desaturation response endpoint.
Patient experience also improved. At 12 months, 89.8% of respondents reported being extremely or somewhat satisfied with Genio, and 69.6% of bed partners reported no or soft snoring compared with 16.5% at baseline.
Those numbers are responder data, not promises. Some patients respond more than others. Follow-up sleep testing shows what the therapy is doing once settings have been established.
CPAP uses pressurized air delivered through a mask to keep the airway from collapsing. It does not require an implant and remains an effective treatment for many people with obstructive sleep apnea.
Genio takes another route. It stimulates tongue muscles through the hypoglossal nerves so the tongue moves forward during sleep.
A patient who sleeps well with CPAP and has good control may have little reason to move away from it. Genio enters the conversation when standard treatment has failed, cannot be tolerated, or does not fit the patient’s medical situation.
For someone who has spent months adjusting straps at 2 a.m., that distinction is concrete.
Genio and Inspire both use hypoglossal nerve stimulation to treat obstructive sleep apnea. Their hardware and nighttime routines differ.
Genio uses one battery-free implant under the chin and stimulates hypoglossal nerve branches on both sides. An external activation chip powers treatment through an adhesive patch worn during sleep.
Inspire uses an implanted pulse generator and stimulation system controlled by the patient with an external remote.
The better question is not which device sounds newer. It is which treatment matches the patient’s airway, sleep-study findings, prior treatment, health history, and preferences.
ENT Specialists already treats sleep apnea with several approaches, which gives the consultation room for that comparison.
Genio requires surgery and carries risks associated with implantation and nerve stimulation.
Potential risks include:
Medical conditions, medications, airway structure, and prior head and neck treatment can change individual risk.
This part of the consultation should be concrete. A mask-free treatment still requires an implant, healing, programming, and follow-up.
The cost of Genio sleep apnea treatment in Novi depends on the medical work required before, during, and after surgery. Insurance coverage also plays a large role.
Cost may include:
Insurance authorization may require records showing the diagnosis, AHI, prior PAP use, and other treatment attempts.
ENT Specialists does not treat Genio as a retail device with one phone price. The medical evaluation establishes candidacy first. From there, the team can address authorization, coverage, and expected patient responsibility based on the treatment plan.
Sleep apnea treatment should start with the airway, not a favorite device.
ENT Specialists provides comprehensive sleep apnea care across Novi, Brighton, and Bingham Farms. The practice already evaluates and treats patients with CPAP therapy, Inspire Therapy, AIRLIFT procedures, and sleep apnea surgery. That range gives physicians room to recommend the option that fits the obstruction rather than pushing every patient toward the same treatment.
The practice also brings the perspective of a multi-physician ENT team that treats nasal obstruction, throat conditions, airway problems, and head and neck concerns. Sleep apnea sits inside that larger system.
For a patient comparing Genio with CPAP, Inspire, an oral appliance, or another surgical treatment, that broader view is useful. The plan starts with what happens to the airway after sleep begins.
If CPAP has failed to control your obstructive sleep apnea or you cannot use it enough to benefit, Genio may be worth discussing.
Call ENT Specialists in Novi at (248) 477-7020 to schedule a sleep apnea consultation. ENT Specialists also serves patients at its Brighton and Bingham Farms locations.
Yes. The FDA approved Genio System 2.1 in August 2025 for select adults age 22 and older with moderate to severe obstructive sleep apnea and an AHI between 15 and 65 who meet the treatment criteria.
No. The stimulator implanted under the chin has no internal battery. A rechargeable activation chip worn on an adhesive patch powers the implant during sleep.
Yes. Before bed, the activation chip connects to a disposable patch placed under the chin. The wearable comes off in the morning, and the chip goes back on its charger.
No chest generator is implanted. Genio uses one surgical incision under the chin for its battery-free stimulator.
Genio may be an option for select patients whose standard sleep apnea treatments have failed, cannot be tolerated, or are not appropriate. Patients who control their OSA well with CPAP may have no medical reason to change treatment.
No. Both treatments stimulate the hypoglossal nerve, but the systems use different implant designs and nighttime controls. Genio uses a battery-free under-chin implant powered by an external wearable and provides bilateral stimulation.
Cost depends on insurance coverage, diagnostic testing, surgery, anesthesia, facility fees, the implant, and follow-up care. ENT Specialists can provide more specific financial guidance once candidacy and insurance requirements have been reviewed.
You're entitled to a higher quality of life. At ENT Specialists, our warm and compassionate team will keep you comfortable and happy throughout your relief journey. Schedule your one-on-one consultation today to experience the difference ENT Specialists can make in your life! We offer ENT treatments in Novi, Brighton, and Bingham Farms.
25500 Meadowbrook Road Suite 220, Novi, MI 48375